Stocks

Stock Market News

20 stories
NEWS reuters

Russia's Rosatom to buy controlling stake in logistics group Delo

Russia's state nuclear corporation Rosatom will acquire a controlling stake in Russian logistics group Delo from businessman Sergei Shishkarev, Russian news agencies reported on Monday, citing Rosatom CEO Alexei Likhachev.Rosatom already owns 49% of Delo, one of Russia's largest logistics operators…

Reuters en
StocksRU
gurufocus

SkyWest Stock Falls After Goldman Sachs Downgrade

SkyWest NASDAQ:SKYW shares fell more than 1.5% on Thursday after Goldman Sachs downgraded the regional airline to Neutral from Buy, citing growing concerns that slower aircraft utilization could weigh on earnings.Goldman also reduced its price target on SkyWest to $108 from $126 after lowering its…

GuruFocus en
StocksUS
thenewswire

Copper One Resources Corp. Announces $9,750,000 Non-Brokered Special Warrant Offering

(TheNewswire)Vancouver, BC – TheNewswire - July 6, 2026 – Copper One Resources Corp. ("Copper One" or the "Company") (CSE:CEXY | OTCID:CEXYF | FSE:IW8 | WKN: A42AGR) is pleased to announce a non-brokered private placement of up to 19,500,000 special warrants of the Company (each, a “Special Warrant…

TheNewswire en
ETFsStocksCA
NEWS thenewswire

Beauce Gold Fields Phase 1 Drilling Confirms a Broad Shallow Gold Zone at Grondin, Including 5.0 m @ 1.90 g/t Au and 1.0 m @ 6.59 g/t Au

(TheNewswire)July 6, 2026 – TheNewswire - Beauce Gold Fields Inc. (Champs d’Or en Beauce) (TSX Venture: BGF) ("BGF" or the "Company") is pleased to announce assay results from Phase 1 of its 2026 diamond drill program at the Grondin Zone, located within the Company’s Beauce Gold Project in Beaucevi…

TheNewswire en
FuturesStocksCA
acceswire

As the Ebola Epidemic Spreads, NanoViricides Advances Towards a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo

SHELTON, CT / ACCESS Newswire / July 6, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, updates that it has continued to advance its broad-spectrum antiviral drug NV-387 towards a Phase II Clinical Trial…

ACCESS Newswire en
EconomyStocksUS
acceswire

Tecogen Business Update

NORTH BILLERICA, MA / ACCESS Newswire / July 6, 2026 / Tecogen Inc. (NYSE American:TGEN), a leading manufacturer of clean energy products and efficient on-site power and cooling solutions, is pleased to announce:Russell ReconstitutionRussell indexes are widely used by investment managers and instit…

ACCESS Newswire en
indexStocksUS
NEWS acceswire

The Next Chapter of AI Is an Infrastructure Story

By Denise Dignam, President & CEO, ChemoursNORTHAMPTON, MA / ACCESS Newswire / July 6, 2026 / Much of the conversation around artificial intelligence understandably focuses on models, compute power, and software innovation. Yet after participating in discussions at the Rome Conference on AI, Ethics…

ACCESS Newswire en
StocksUS
NEWS prnewswire

ePlus Appoints John Lutz to Board of Directors

HERNDON, Va., July 6, 2026 /PRNewswire/ -- ePlus inc. (NASDAQ NGS: PLUS – news) today announced that John Lutz, a senior executive with more than 30 years' experience across global technology and institutional environments, has joined its Board of Directors.Currently Vice Chancellor for Development…

PR Newswire en
StocksUS